Eon-backed fuel cell technology developer Bloom Energy was rumoured to be seeking an initial public offering in 2016 and has not made any funding announcements since then.

The UCL spinout has set the pricing range at $15 to $17 and stands to raise nearly $144m in proceeds if underwriters take up their 30-day option.

Kadmon-backed gene therapy developer MeiraGTx has gone public on Nasdaq after raising $75m in proceeds in its initial public offering.

Forty Seven, a GV-backed immuno-oncology spinout from Stanford University, has filed for a $115m initial public offering on Nasdaq just eight months after closing a $75m series B.

Forty Seven, a GV-backed immuno-oncology spinout from Stanford University, has filed for a $115m initial public offering on Nasdaq just eight months after closing a $75m series B.

United, Mitsui, Itochu and GMO-backed e-commerce platform Mercari has priced its initial public offering at the top of its range and will raise up to $1.19bn in Tokyo this month.

M17 Entertainment, backed by MCN, Yahoo Japan and LeSports, was expected to float on the New York Stock Exchange yesterday but still has not begun trading.

The Rocket Internet-backed meal ingredients delivery service is planning to raise $53m in an initial public offering on the Australian Securities Exchange.

The smartphone manufacturer, which filed for a $10bn initial public offering in May, is planning to raise up to 30% of the amount in mainland China and the remainder in Hong Kong.

Pharmstandard and Access Industries-backed Neon Therapeutics has filed for a $115m initial public offering that will support a range of ongoing clinical trials.